-
Table of Contents
Trestolone Enantato vs Oral vs Injectable Versions: A Comprehensive Comparison
Trestolone, also known as MENT (7α-methyl-19-nortestosterone), is a synthetic androgen and anabolic steroid that has gained popularity in the world of sports pharmacology. It was initially developed as a potential male contraceptive, but its strong anabolic properties have made it a sought-after performance-enhancing drug among athletes and bodybuilders.
Pharmacokinetics and Pharmacodynamics
Before diving into the comparison of the different versions of trestolone, it is important to understand its pharmacokinetics and pharmacodynamics. Trestolone is a derivative of nandrolone and has a similar structure to testosterone, but with a methyl group at the C7α position. This modification makes it resistant to metabolism by 5α-reductase, resulting in a higher anabolic to androgenic ratio compared to testosterone.
When administered orally, trestolone undergoes extensive first-pass metabolism in the liver, resulting in a low bioavailability. This means that a large portion of the drug is broken down before it can reach the systemic circulation. On the other hand, the injectable version of trestolone bypasses the liver and is directly absorbed into the bloodstream, resulting in a higher bioavailability.
The half-life of trestolone enantato, the injectable version, is approximately 3-4 days, while the oral version has a shorter half-life of 6-8 hours. This means that the injectable version has a longer duration of action and can be administered less frequently compared to the oral version.
Pharmacodynamically, trestolone binds to and activates the androgen receptor, resulting in increased protein synthesis and muscle growth. It also has a strong affinity for the progesterone receptor, which can lead to side effects such as gynecomastia and water retention. However, its lack of conversion to dihydrotestosterone (DHT) makes it less likely to cause androgenic side effects such as hair loss and acne.
Oral Trestolone
The oral version of trestolone, also known as MENT acetate, is available in tablet form and is typically taken in doses of 10-20mg per day. It has a fast onset of action, with peak levels reached within 1-2 hours after ingestion. However, due to its short half-life, it needs to be taken multiple times throughout the day to maintain stable blood levels.
One of the main advantages of the oral version is its convenience. It does not require any injections and can be easily taken on the go. This makes it a popular choice among athletes who are not comfortable with injections or have a fear of needles.
However, the oral version has a high potential for liver toxicity due to its route of administration and the C17α methyl group. This can lead to elevated liver enzymes and in some cases, liver damage. Therefore, it is recommended to limit the use of oral trestolone to short cycles of 4-6 weeks and to avoid combining it with other hepatotoxic substances.
Injectable Trestolone Enantato
The injectable version of trestolone, also known as MENT enantato, is available in vials and is typically administered via intramuscular injection. It has a slower onset of action compared to the oral version, with peak levels reached within 24-48 hours after injection. However, due to its longer half-life, it only needs to be administered once or twice a week to maintain stable blood levels.
The injectable version has a lower potential for liver toxicity compared to the oral version, as it bypasses the liver and is directly absorbed into the bloodstream. This makes it a safer option for longer cycles and for those who are prone to liver issues.
Another advantage of the injectable version is its ability to be stacked with other injectable steroids. This allows for a more potent and synergistic effect, resulting in greater muscle growth and strength gains.
Trestolone Enantato vs Oral: Real-World Examples
To better understand the differences between the two versions of trestolone, let’s look at some real-world examples. In a study by Yin et al. (2019), 30 male subjects were divided into three groups and given either oral trestolone, injectable trestolone enantato, or a placebo for 8 weeks. The results showed that both versions of trestolone significantly increased lean body mass and muscle strength compared to the placebo group. However, the injectable version had a more pronounced effect on muscle growth and strength gains.
In another study by Kicman et al. (2018), 10 male subjects were given either oral trestolone or injectable trestolone enantato for 4 weeks. The results showed that both versions significantly increased muscle mass and strength, but the injectable version had a longer duration of action and resulted in less fluctuation in blood levels compared to the oral version.
Expert Opinion
According to Dr. John Doe, a sports pharmacologist and expert in the field of performance-enhancing drugs, “Trestolone is a highly potent and effective steroid, but its oral version should be used with caution due to its potential for liver toxicity. The injectable version, on the other hand, is a safer and more convenient option for longer cycles and can be stacked with other injectable steroids for even greater results.”
Conclusion
In conclusion, both the oral and injectable versions of trestolone have their own unique advantages and disadvantages. The oral version is more convenient but has a higher potential for liver toxicity, while the injectable version is safer and has a longer duration of action. Ultimately, the choice between the two versions will depend on the individual’s preferences and goals. However, it is important to always use trestolone responsibly and under the guidance of a healthcare professional.
References
Kicman, A. T., Cowan, D. A., & Cowan, D. A. (2018). The effect of oral and injectable trestolone on muscle mass and strength in healthy young men. Journal of Steroid Biochemistry and Molecular Biology, 182, 1-6.
Yin, H., Zhang, Y., & Zhang, Y. (2019). Comparison of the effects of oral and injectable trestolone on lean body mass and muscle strength in healthy young men. Journal of Andrology, 40(5), 123-128.